Skip to content
sellWeak

Gilde Healthcare U.A. Cooperatieve IV sold $198k of LVTX

owner at LAVA Therapeutics NV. 126,992 shares at an average of $1.56, traded Oct 8, 2025, filed Oct 10, 2025.

Warning score
24
Value
$198k
126,992 shares
Holdings after
5,294,178
-2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    10% owner
    +12
  • Trade size
    $198k at market
    +12
  • Share of holdings sold
    Sold 2.3% of holdings
    0
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001193125-25-237275, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Oct 8, 2025SOpen-market sale
Common Shares
-28,954$1.57$45k5,392,216Oct 10, 2025
Oct 9, 2025SOpen-market sale
Common Shares
-48,169$1.56$75k5,344,047Oct 10, 2025
Oct 10, 2025SOpen-market sale
Common Shares
-49,869$1.55$77k5,294,178Oct 10, 2025

Related signals

Other insiders at LAVA Therapeutics NV and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
57Moderate
LVTXsell
LAVA Therapeutics NV
Gilde Healthcare U.A. Cooperatieve IV
owner
$4.2M
2,871,370 shares
-97%
33Weak
LVTXsell
LAVA Therapeutics NV
Gilde Healthcare U.A. Cooperatieve IV
owner
$719k
475,027 shares
-9%
57Moderate
LVTXsell
LAVA Therapeutics NV
Versant Venture Capital VI, L.P.
owner
$4.1M
2,903,403 shares
-122%
47Moderate
LVTXsell
LAVA Therapeutics NV
Versant Venture Capital VI, L.P.
owner
$2.5M
1,684,434 shares
-49%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Gilde Healthcare U.A. Cooperatieve IV sold $198k of LVTX | InsiderTell